175 related articles for article (PubMed ID: 3019713)
1. Neuromedin N: high affinity interaction with brain neurotensin receptors and rapid inactivation by brain synaptic peptidases.
Checler F; Vincent JP; Kitabgi P
Eur J Pharmacol; 1986 Jul; 126(3):239-44. PubMed ID: 3019713
[TBL] [Abstract][Full Text] [Related]
2. Stability of [D-Trp11]-neurotensin to rat brain peptidases.
McDermott JR; Gibson AM; Biggins JA
Neurosci Lett; 1986 Dec; 72(1):79-83. PubMed ID: 3543750
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of neurotensin and neuromedin N by Zn metallopeptidases.
Kitabgi P
Peptides; 2006 Oct; 27(10):2515-22. PubMed ID: 16904239
[TBL] [Abstract][Full Text] [Related]
4. Calcium-dependent release of neuromedin N and neurotensin from mouse hypothalamus.
Kitabgi P; De Nadai F; Cuber JC; Dubuc I; Nouel D; Costentin J
Neuropeptides; 1990 Feb; 15(2):111-4. PubMed ID: 2080018
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of neurotensin by rat brain synaptic membranes. Cleavage at the Pro10-Tyr11 bond by endopeptidase 24.11 (enkephalinase) and a peptidase different from proline-endopeptidase.
Checler F; Emson PC; Vincent JP; Kitabgi P
J Neurochem; 1984 Nov; 43(5):1295-301. PubMed ID: 6387047
[TBL] [Abstract][Full Text] [Related]
6. Differential catabolic fate of neuromedin N and neurotensin in the canine intestinal mucosa.
Barelli H; Mao YK; Vincent B; Daniel EE; Vincent JP; Checler F
Peptides; 1993; 14(3):457-63. PubMed ID: 8332546
[TBL] [Abstract][Full Text] [Related]
7. Neurotensin analogs [D-TYR11] and [D-PHE11]neurotensin resist degradation by brain peptidases in vitro and in vivo.
Checler F; Vincent JP; Kitabgi P
J Pharmacol Exp Ther; 1983 Dec; 227(3):743-8. PubMed ID: 6361231
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and binding characteristics of [(3)H]neuromedin N, a NTS2 receptor ligand.
Tóth F; Mallareddy JR; Tourwé D; Lipkowski AW; Bujalska-Zadrozny M; Benyhe S; Ballet S; Tóth G; Kleczkowska P
Neuropeptides; 2016 Jun; 57():15-20. PubMed ID: 26707235
[TBL] [Abstract][Full Text] [Related]
9. Neurotensin and neuromedin N stimulate mucin output from human goblet cells (Cl.16E) via neurotensin receptors.
Augeron C; Voisin T; Maoret JJ; Berthon B; Laburthe M; Laboisse CL
Am J Physiol; 1992 Mar; 262(3 Pt 1):G470-6. PubMed ID: 1312794
[TBL] [Abstract][Full Text] [Related]
10. Neuromedin-N is not released with neurotensin from rat ileum.
Cuber JC; Herrmann C; Kitabgi P; Bosshard A; Bernard C; De Nadai F; Chayvialle JA
Endocrinology; 1990 Mar; 126(3):1584-92. PubMed ID: 2307120
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological role and degradation processes of neuromedin N in the gastrointestinal tract: an in vitro and in vivo study.
Barelli H; Woskowska Z; Cipris S; Fox-Threlkeld JE; Daniel EE; Vincent JP; Checler F
J Pharmacol Exp Ther; 1995 Dec; 275(3):1300-7. PubMed ID: 8531096
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin-metabolizing peptidases in rat fundus plasma membranes.
Checler F; Barelli H; Kwan CY; Kitabgi P; Vincent JP
J Neurochem; 1987 Aug; 49(2):507-12. PubMed ID: 3298547
[TBL] [Abstract][Full Text] [Related]
13. High-affinity receptor sites and rapid proteolytic inactivation of neurotensin in primary cultured neurons.
Checler F; Mazella J; Kitabgi P; Vincent JP
J Neurochem; 1986 Dec; 47(6):1742-8. PubMed ID: 3021902
[TBL] [Abstract][Full Text] [Related]
14. Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases.
Checler F; Vincent JP; Kitabgi P
J Neurochem; 1983 Aug; 41(2):375-84. PubMed ID: 6308159
[TBL] [Abstract][Full Text] [Related]
15. Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line.
Bidard JN; de Nadai F; Rovere C; Moinier D; Laur J; Martinez J; Cuber JC; Kitabgi P
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):225-33. PubMed ID: 8471039
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of a novel neurotensin-degrading peptidase from rat brain synaptic membranes.
Checler F; Vincent JP; Kitabgi P
J Biol Chem; 1986 Aug; 261(24):11274-81. PubMed ID: 3525564
[TBL] [Abstract][Full Text] [Related]
17. Molecular properties of neurotensin receptors in rat brain. Identification of subunits by covalent labeling.
Mazella J; Kitabgi P; Vincent JP
J Biol Chem; 1985 Jan; 260(1):508-14. PubMed ID: 2981215
[TBL] [Abstract][Full Text] [Related]
18. Differential processing of the neurotensin/neuromedin N precursor in the mouse.
Shaw C; McKay D; Johnston CF; Halton DW; Fairweather I; Kitabgi P; Buchanan KD
Peptides; 1990; 11(2):227-35. PubMed ID: 2356154
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evidence for the involvement of protein convertases 5A and 2 in the processing of pro-neurotensin in rat brain.
Villeneuve P; Lafortune L; Seidah NG; Kitabgi P; Beaudet A
J Comp Neurol; 2000 Aug; 424(3):461-75. PubMed ID: 10906713
[TBL] [Abstract][Full Text] [Related]
20. Importance of thiol group(s) in the binding of 125I-labeled neurotensin to membranes from porcine brain.
Mitra SP; Carraway RE
Peptides; 1993; 14(2):185-9. PubMed ID: 8387186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
